Detection of prolonged mixed hematopoetic chimerism after allogeneic stem cell transplantation with non-myeloablative conditioning in patients with advanced low-grade lymphoproliferative disorders

被引：0
|
作者：
Marinets, O
Thiel, E
Leschinger, N
Krause, K
Knauf, WU
Blau, WI
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [1] Quantitative analysis of chimerism after allogeneic stem cell transplantation with non-myeloablative conditioning in paediatric patients
    Di Martino, D.
    Terranova, M. P.
    Di Duca, M.
    Faraci, M.
    Dallorso, S.
    Miano, M.
    Dini, G.
    Morreale, G.
    Lanino, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S302 - S303
  • [2] Non-myeloablative conditioning regimen for allogeneic stem cell transplantation in patients with advanced hematological malignancies
    Malesevic, M
    Stamatovic, D
    Tukic, L
    Marjanovic, S
    Balint, B
    Tarabar, O
    Todoric, B
    Ristic, L
    Milicevic, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S294 - S295
  • [3] Detection of hematopoetic chimerism after allogeneic stem cell transplantation
    Marinets, O
    Fehse, B
    Vorwig, O
    Zabelina, T
    Kroger, N
    Kruger, W
    Renges, H
    Kabisch, H
    Afanassiev, B
    Zander, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S347 - S347
  • [4] Different immune reconstitution in patients with lymphoproliferative diseases after non-myeloablative and myeloablative allogeneic stem cell transplantation
    Dattola, A
    Condemi, A
    Cuzzola, M
    Iacopino, O
    Pontari, A
    Callea, I
    Martino, M
    Pucci, G
    Messina, G
    Irrera, G
    Console, G
    Marcuccio, D
    Morabito, F
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S358 - S358
  • [5] Low rates of chimerism occur when alemtuzumab is added to conditioning therapy for non-myeloablative allogeneic stem cell transplantation
    Kasner, M.
    Loren, A.
    Stein, S.
    Goldstein, S.
    Luger, S.
    Nasta, S.
    Perl, A.
    Schuster, S.
    Tsai, D.
    Andreadis, B.
    Smith, J.
    Cole, S.
    Hinkle, J.
    Pillai, P.
    Emerson, S.
    Stadtmauer, E.
    Porter, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 92 - 92
  • [6] Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation.
    Iannone, R
    Luznik, L
    Engstrom, LW
    Fuchs, EJ
    BLOOD, 1999, 94 (10) : 320B - 321B
  • [7] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [8] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic haematopoietic stem cell transplantation
    Plesa, A.
    Le, Q.
    Revesz, D.
    Thomas, X.
    Ducastelle, S.
    Nicolini, F. E.
    Michallet, A. S.
    Mollet, I.
    Dubois, V.
    Clark, M.
    Dumontet, C.
    Raus, N.
    Sobh, M.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S336 - S336
  • [9] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation
    Plesa, Adriana
    Lee, Quoc-Hung
    Revesz, Daniela
    Thomas, Xavier
    Ducastelle, Sophie
    Nicolini, Franck E.
    Michallet, Anne-Sophie
    Mollet, Isabelle
    Dubois, Valerie
    Clark, Melisa
    Dumontet, Charles
    Raus, Nicole
    Michallet, Mauricette
    BLOOD, 2007, 110 (11) : 341B - 342B
  • [10] Tandem autologous stem cell transplantation or non-myeloablative allogeneic stem cell transplantation following autologous stem cell transplantation for transformed low-grade lymphoma
    Dubruille, V
    Morineau, N
    Moreau, P
    Guillaume, T
    Mahe, B
    Chevalier, P
    Harousseau, J
    Milpied, N
    BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S250
12345